Biglycan in hepatorenal crosstalk Biglycan: a regulator of hepatorenal inflammation and autophagy.

[1]  R. Iozzo,et al.  A functional outside-in signaling network of proteoglycans and matrix molecules regulating autophagy. , 2021, Matrix biology : journal of the International Society for Matrix Biology.

[2]  G. Eknoyan,et al.  Hepatorenal Syndrome: A historical appraisal of its origins and conceptual evolution. , 2021, Kidney international.

[3]  G. Yılmaz,et al.  Serum Biglycan as a Diagnostic Marker for Non-Alcoholic Steatohepatitis and Liver Fibrosis. , 2021, Clinical laboratory.

[4]  S. Selleck,et al.  Putting the Brakes on Autophagy: The role of Heparan Sulfate Modified Proteins in the Balance of Anabolic and Catabolic Pathways and Intracellular Quality Control. , 2021, Matrix biology : journal of the International Society for Matrix Biology.

[5]  B. He,et al.  Ginsenoside Rg1 alleviates acute liver injury through the induction of autophagy and suppressing NF-κB/NLRP3 inflammasome signaling pathway , 2021, International journal of medical sciences.

[6]  Lina Herhaus.  TBK1 (TANK-binding kinase 1)-mediated regulation of autophagy in health and disease. , 2021, Matrix biology : journal of the International Society for Matrix Biology.

[7]  M. Hébert,et al.  Autophagy, tissue repair, and fibrosis: a delicate balance. , 2021, Matrix biology : journal of the International Society for Matrix Biology.

[8]  P. Ye,et al.  PBMC transcriptomics identifies immune-metabolism disorder during the development of HBV-ACLF , 2021, Gut.

[9]  Nina Kurrle,et al.  Amino acid sensory complex proteins in mTORC1 and macroautophagy regulation. , 2021, Matrix biology : journal of the International Society for Matrix Biology.

[10]  M. Karsdal,et al.  Comprehensive assessment of ECM turnover using serum biomarkers establishes PBC as a high-turnover autoimmune liver disease , 2020, JHEP reports : innovation in hepatology.

[11]  R. Moreau,et al.  Acute-on-chronic liver failure: Definitions, pathophysiology and principles of treatment , 2020, JHEP reports : innovation in hepatology.

[12]  R. Moreau,et al.  The Systemic Inflammation Hypothesis: Towards a New Paradigm of Acute Decompensation and Multiorgan Failure in Cirrhosis. , 2020, Journal of hepatology.

[13]  C. Junot,et al.  Assessing the role of amino acids in systemic inflammation and organ failure in patients with ACLF. , 2020, Journal of hepatology.

[14]  K. Winklhofer,et al.  Protein quality control by the proteasome and autophagy: A regulatory role of ubiquitin and liquid-liquid phase separation. , 2020, Matrix biology : journal of the International Society for Matrix Biology.

[15]  R. Iozzo,et al.  Decorin Regulates Cartilage Pericellular Matrix Micromechanobiology. , 2020, Matrix biology : journal of the International Society for Matrix Biology.

[16]  P. Gao,et al.  HIF-1α-BNIP3-mediated mitophagy in tubular cells protects against renal ischemia/reperfusion injury , 2020, Redox biology.

[17]  C. Corrado,et al.  Hypoxia and HIF Signaling: One Axis with Divergent Effects , 2020, International journal of molecular sciences.

[18]  M. Manns,et al.  The PREDICT study uncovers three clinical courses in acutely decompensated cirrhosis with distinct pathophysiology (120/120). , 2020, Journal of Hepatology.

[19]  R. Iozzo,et al.  Proteoglycan-driven Autophagy: A Nutrient-independent Mechanism to Control Intracellular Catabolism , 2020, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[20]  B. Loeys,et al.  Biglycan in the Skeleton , 2020, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[21]  J. Trebicka,et al.  Communications via the Small Leucine-rich Proteoglycans: Molecular Specificity in Inflammation and Autoimmune Diseases , 2020, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[22]  J. Trebicka,et al.  Danger matrix molecules orchestrate CD14/CD44 signaling in cancer development. , 2020, Seminars in cancer biology.

[23]  R. Iozzo,et al.  Proteoglycan signaling in tumor angiogenesis and endothelial cell autophagy. , 2020, Seminars in cancer biology.

[24]  M. Scuruchi,et al.  Biglycan and atherosclerosis: Lessons from high cardiovascular risk conditions. , 2020, Biochimica et biophysica acta. Molecular and cell biology of lipids.

[25]  B. Colsch,et al.  Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF. , 2019, Journal of hepatology.

[26]  Xiao-Ming Yin,et al.  Autophagy, Metabolism, and Alcohol-Related Liver Disease: Novel Modulators and Functions , 2019, International journal of molecular sciences.

[27]  L. Schaefer,et al.  Breaking down chronic inflammatory diseases: the role of biglycan in promoting a switch between inflammation and autophagy , 2019, The FEBS journal.

[28]  S. Fulda,et al.  Biglycan is a new high-affinity ligand for CD14 in macrophages. , 2019, Matrix biology : journal of the International Society for Matrix Biology.

[29]  A. de Gottardi,et al.  Addressing Profiles of Systemic Inflammation Across the Different Clinical Phenotypes of Acutely Decompensated Cirrhosis , 2019, Front. Immunol..

[30]  P. Boor,et al.  Biglycan evokes autophagy in macrophages via a novel CD44/Toll-like receptor 4 signaling axis in ischemia/reperfusion injury. , 2019, Kidney international.

[31]  H. Lan,et al.  Macrophages: versatile players in renal inflammation and fibrosis , 2019, Nature Reviews Nephrology.

[32]  Li Tang,et al.  N-Acetylcysteine Ameliorates Gentamicin-Induced Nephrotoxicity by Enhancing Autophagy and Reducing Oxidative Damage in Miniature Pigs , 2019, Shock.

[33]  Pan Fan,et al.  Molecular Regulation Mechanisms and Interactions Between Reactive Oxygen Species and Mitophagy. , 2019, DNA and cell biology.

[34]  A. Theocharis,et al.  Proteoglycans remodeling in cancer: Underlying molecular mechanisms. , 2017, Matrix biology : journal of the International Society for Matrix Biology.

[35]  R. Iozzo,et al.  Decorin is a devouring proteoglycan: Remodeling of intracellular catabolism via autophagy and mitophagy. , 2017, Matrix biology : journal of the International Society for Matrix Biology.

[36]  R. Heidari,et al.  Mitochondrial dysfunction as a mechanism involved in the pathogenesis of cirrhosis-associated cholemic nephropathy. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[37]  Nikos K. Karamanos,et al.  Matrix modeling and remodeling: A biological interplay regulating tissue homeostasis and diseases. , 2019, Matrix biology : journal of the International Society for Matrix Biology.

[38]  G. Christensen,et al.  Sweet, yet underappreciated: Proteoglycans and extracellular matrix remodeling in heart disease. , 2019, Matrix biology : journal of the International Society for Matrix Biology.

[39]  Ahmed M. Ashmawy,et al.  Significance of biglycan and osteopontin as non-invasive markers of liver fibrosis in patients with chronic hepatitis B virus and chronic hepatitis C virus , 2018, Journal of Investigative Medicine.

[40]  Z. Radi.  Immunopathogenesis of Acute Kidney Injury , 2018, Toxicologic pathology.

[41]  R. Iozzo,et al.  Extracellular matrix: The driving force of mammalian diseases. , 2018, Matrix biology : journal of the International Society for Matrix Biology.

[42]  T. Wight.  A role for proteoglycans in vascular disease. , 2018, Matrix biology : journal of the International Society for Matrix Biology.

[43]  R. Moreau,et al.  Systemic Inflammation and Acute-on-Chronic Liver Failure: Too Much, Not Enough , 2018, Canadian journal of gastroenterology & hepatology.

[44]  L. Schaefer.  Decoding fibrosis: Mechanisms and translational aspects. , 2018, Matrix biology : journal of the International Society for Matrix Biology.

[45]  B. Hinz,et al.  The big five in fibrosis: Macrophages, myofibroblasts, matrix, mechanics, and miscommunication. , 2018, Matrix biology : journal of the International Society for Matrix Biology.

[46]  Yunhu Bai,et al.  Hepatic encephalopathy changes mitochondrial dynamics and autophagy in the substantia nigra , 2018, Metabolic Brain Disease.

[47]  G. Gores,et al.  Non-alcoholic steatohepatitis pathogenesis: sublethal hepatocyte injury as a driver of liver inflammation , 2018, Gut.

[48]  J. Yount,et al.  Checks and Balances between Autophagy and Inflammasomes during Infection. , 2018, Journal of molecular biology.

[49]  H. François,et al.  Renal fibrosis: Recent translational aspects. , 2017, Matrix biology : journal of the International Society for Matrix Biology.

[50]  L. Schaefer,et al.  Biglycan, a novel trigger of Th1 and Th17 cell recruitment into the kidney. , 2017, Matrix biology : journal of the International Society for Matrix Biology.

[51]  L. Schaefer,et al.  Targeting renal fibrosis: Mechanisms and drug delivery systems , 2017, Advanced drug delivery reviews.

[52]  M. Mack.  Inflammation and fibrosis. , 2017, Matrix biology : journal of the International Society for Matrix Biology.

[53]  A. L. Mindikoglu,et al.  New Developments in Hepatorenal Syndrome , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[54]  L. Schaefer,et al.  Danger-Associated Molecular Patterns Derived From the Extracellular Matrix Provide Temporal Control of Innate Immunity , 2018, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[55]  L. Schaefer,et al.  Small Leucine-Rich Proteoglycans in Renal Inflammation: Two Sides of the Coin , 2018, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[56]  M. Cengiz,et al.  The importance of serum biglycan levels as a fibrosis marker in patients with chronic hepatitis B , 2017, Journal of clinical laboratory analysis.

[57]  Mengjia Qian,et al.  Autophagy and inflammation , 2017, Clinical and Translational Medicine.

[58]  Sun-Mee Lee,et al.  2‐Methoxyestradiol protects against ischemia/reperfusion injury in alcoholic fatty liver by enhancing sirtuin 1‐mediated autophagy , 2017, Biochemical pharmacology.

[59]  P. Angeli,et al.  Validation of a Staging System for Acute Kidney Injury in Patients With Cirrhosis and Association With Acute‐on‐Chronic Liver Failure , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[60]  M. Komatsu,et al.  Autophagy in the liver: functions in health and disease , 2017, Nature Reviews Gastroenterology &Hepatology.

[61]  R. Brandes,et al.  Biglycan- and Sphingosine Kinase-1 Signaling Crosstalk Regulates the Synthesis of Macrophage Chemoattractants , 2017, International journal of molecular sciences.

[62]  R. Iozzo,et al.  Proteoglycan neofunctions: regulation of inflammation and autophagy in cancer biology , 2017, The FEBS journal.

[63]  D. Brenner,et al.  Identifying nonalcoholic fatty liver disease patients with active fibrosis by measuring extracellular matrix remodeling rates in tissue and blood , 2016, Hepatology.

[64]  R. Moreau,et al.  The Acute-on-Chronic Liver Failure Syndrome, or When the Innate Immune System Goes Astray , 2016, The Journal of Immunology.

[65]  Richard Moreau,et al.  Systemic inflammation in decompensated cirrhosis: Characterization and role in acute‐on‐chronic liver failure , 2016, Hepatology.

[66]  Sylvain D. Vallet,et al.  Decorin interacting network: A comprehensive analysis of decorin-binding partners and their versatile functions. , 2016, Matrix biology : journal of the International Society for Matrix Biology.

[67]  Yi Pan,et al.  PAQR3 controls autophagy by integrating AMPK signaling to enhance ATG14L‐associated PI3K activity , 2016, The EMBO journal.

[68]  R. Brandes,et al.  Bimodal role of NADPH oxidases in the regulation of biglycan-triggered IL-1β synthesis. , 2016, Matrix biology : journal of the International Society for Matrix Biology.

[69]  M. Karsdal,et al.  Collagen and tissue turnover as a function of age: Implications for fibrosis. , 2016, Journal of hepatology.

[70]  H. Fuchs,et al.  A novel biological function of soluble biglycan: Induction of erythropoietin production and polycythemia , 2016, Glycoconjugate Journal.

[71]  H. Fox,et al.  Acute and Chronic Ethanol Administration Differentially Modulate Hepatic Autophagy and Transcription Factor EB. , 2015, Alcoholism, clinical and experimental research.

[72]  R. Moreau,et al.  Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis. , 2015, Journal of hepatology.

[73]  R. Iozzo,et al.  Proteoglycans regulate autophagy via outside-in signaling: an emerging new concept. , 2015, Matrix biology : journal of the International Society for Matrix Biology.

[74]  P. Agostinis,et al.  Autophagy and the Kidney: Implications for Ischemia-Reperfusion Injury and Therapy. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[75]  C. Ronco,et al.  Cardiorenal Syndrome Type 5: In Vitro Cytotoxicity Effects on Renal Tubular Cells and Inflammatory Profile , 2015, Analytical cellular pathology.

[76]  R. Moreau,et al.  Acute-on-chronic liver failure: A new syndrome that will re-classify cirrhosis. , 2015, Journal of hepatology.

[77]  Renato V. Iozzo,et al.  Proteoglycan form and function: A comprehensive nomenclature of proteoglycans , 2015, Matrix Biology.

[78]  S. Ryter,et al.  Oxidative stress and autophagy: Crucial modulators of kidney injury , 2015, Redox biology.

[79]  A. Davenport,et al.  Renal dysfunction in cirrhosis is not just a vasomotor nephropathy , 2014, Kidney international.

[80]  L. Schaefer.  Complexity of Danger: The Diverse Nature of Damage-associated Molecular Patterns* , 2014, The Journal of Biological Chemistry.

[81]  D. Green,et al.  Synchronized renal tubular cell death involves ferroptosis , 2014, Proceedings of the National Academy of Sciences.

[82]  M. Love,et al.  TRPM2 mediates ischemic kidney injury and oxidant stress through RAC1. , 2014, The Journal of clinical investigation.

[83]  R. Iozzo,et al.  Soluble biglycan as a biomarker of inflammatory renal diseases. , 2014, The international journal of biochemistry & cell biology.

[84]  R. Iozzo,et al.  Instructive roles of extracellular matrix on autophagy. , 2014, The American journal of pathology.

[85]  R. Iozzo,et al.  Key roles for the small leucine-rich proteoglycans in renal and pulmonary pathophysiology. , 2014, Biochimica et biophysica acta.

[86]  Prahlad T. Ram,et al.  A switch in the source of ATP production and a loss in capacity to perform glycolysis are hallmarks of hepatocyte failure in advance liver disease. , 2014, Journal of hepatology.

[87]  J. Pfeilschifter,et al.  Biglycan-triggered TLR-2- and TLR-4-signaling exacerbates the pathophysiology of ischemic acute kidney injury. , 2014, Matrix biology : journal of the International Society for Matrix Biology.

[88]  R. Iozzo,et al.  De novo expression of circulating biglycan evokes an innate inflammatory tissue response via MyD88/TRIF pathways. , 2014, Matrix biology : journal of the International Society for Matrix Biology.

[89]  R. Iozzo,et al.  Decorin activates AMPK, an energy sensor kinase, to induce autophagy in endothelial cells. , 2014, Matrix biology : journal of the International Society for Matrix Biology.

[90]  Z. Dong,et al.  Autophagy in acute kidney injury. , 2014, Seminars in nephrology.

[91]  K. Behrns,et al.  Carbamazepine suppresses calpain-mediated autophagy impairment after ischemia/reperfusion in mouse livers. , 2013, Toxicology and applied pharmacology.

[92]  M. Karsdal,et al.  Novel serological neo-epitope markers of extracellular matrix proteins for the detection of portal hypertension , 2013, Alimentary pharmacology & therapeutics.

[93]  E. Poch,et al.  A modified acute kidney injury classification for diagnosis and risk stratification of impairment of kidney function in cirrhosis. , 2013, Journal of hepatology.

[94]  A. Frigo,et al.  Evaluation of the Acute Kidney Injury Network criteria in hospitalized patients with cirrhosis and ascites. , 2013, Journal of hepatology.

[95]  M. Rosengart,et al.  Augmenting Autophagy to Treat Acute Kidney Injury during Endotoxemia in Mice , 2013, PloS one.

[96]  T. Soga,et al.  Autophagy protects kidney proximal tubule epithelial cells from mitochondrial metabolic stress , 2013, Autophagy.

[97]  M. Czaja,et al.  Inhibition of hepatocyte autophagy increases tumor necrosis factor-dependent liver injury by promoting caspase-8 activation , 2013, Cell Death and Differentiation.

[98]  R. Iozzo,et al.  Decorin causes autophagy in endothelial cells via Peg3 , 2013, Proceedings of the National Academy of Sciences.

[99]  R. Moreau,et al.  Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. , 2013, Gastroenterology.

[100]  R. Iozzo,et al.  Biological interplay between proteoglycans and their innate immune receptors in inflammation , 2013, The FEBS journal.

[101]  X. Chen,et al.  Pharmacological promotion of autophagy alleviates steatosis and injury in alcoholic and non-alcoholic fatty liver conditions in mice. , 2013, Journal of hepatology.

[102]  M. Karsdal,et al.  Protein fingerprinting of the extracellular matrix remodelling in a rat model of liver fibrosis—a serological evaluation , 2013, Liver international : official journal of the International Association for the Study of the Liver.

[103]  J. Debnath,et al.  Autophagy as a stress-response and quality-control mechanism: implications for cell injury and human disease. , 2013, Annual review of pathology.

[104]  D. Rubinsztein,et al.  Autophagy modulation as a potential therapeutic target for diverse diseases , 2012, Nature Reviews Drug Discovery.

[105]  R. Iozzo,et al.  Decorin: a guardian from the matrix. , 2012, The American journal of pathology.

[106]  M. Rosengart,et al.  Calcium/calmodulin-dependent protein kinase IV limits organ damage in hepatic ischemia-reperfusion injury through induction of autophagy. , 2012, American journal of physiology. Gastrointestinal and liver physiology.

[107]  Yunchao Su,et al.  Autophagy in proximal tubules protects against acute kidney injury , 2012, Kidney international.

[108]  R. Iozzo,et al.  Small leucine-rich proteoglycans orchestrate receptor crosstalk during inflammation , 2012, Cell cycle.

[109]  O. Kretz,et al.  Autophagy plays a critical role in kidney tubule maintenance, aging and ischemia-reperfusion injury , 2012, Autophagy.

[110]  A. Sher,et al.  Activation of autophagy by inflammatory signals limits IL-1β production by targeting ubiquitinated inflammasomes for destruction , 2012, Nature Immunology.

[111]  A. Choi,et al.  Autophagy: cellular defense to excessive inflammation. , 2012, Microbes and infection.

[112]  H. Rakugi,et al.  Cardiovascular , Pulmonary , and Renal Pathology Autophagy Guards Against Cisplatin-Induced Acute Kidney Injury , 2012 .

[113]  J. Pfeilschifter,et al.  Signaling by the Matrix Proteoglycan Decorin Controls Inflammation and Cancer Through PDCD4 and MicroRNA-21 , 2011, Science Signaling.

[114]  P. Ginès,et al.  Pharmacological management of hepatorenal syndrome: lessons from non-responders. , 2011, Journal of hepatology.

[115]  J. Fischer,et al.  Deficiency of Biglycan Causes Cardiac Fibroblasts to Differentiate into a Myofibroblast Phenotype* , 2011, The Journal of Biological Chemistry.

[116]  J. Tschopp,et al.  Autophagy Controls IL-1β Secretion by Targeting Pro-IL-1β for Degradation , 2011, The Journal of Biological Chemistry.

[117]  Z. Elazar,et al.  Regulation of autophagy by ROS: physiology and pathology. , 2011, Trends in biochemical sciences.

[118]  N. Gretz,et al.  The proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritis. , 2010, The Journal of clinical investigation.

[119]  R. Iozzo,et al.  Proteoglycans in health and disease: novel regulatory signaling mechanisms evoked by the small leucine‐rich proteoglycans , 2010, The FEBS journal.

[120]  Simon Watkins,et al.  An Autophagy-Enhancing Drug Promotes Degradation of Mutant α1-Antitrypsin Z and Reduces Hepatic Fibrosis , 2010, Science.

[121]  Z. Dong,et al.  Autophagy is a renoprotective mechanism during in vitro hypoxia and in vivo ischemia-reperfusion injury. , 2010, The American journal of pathology.

[122]  E. Christensen,et al.  Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome , 2010, Hepatology.

[123]  J. Pfeilschifter,et al.  Biglycan, a Danger Signal That Activates the NLRP3 Inflammasome via Toll-like and P2X Receptors* , 2009, The Journal of Biological Chemistry.

[124]  N. Gorbunov,et al.  Cardioprotection by adaptation to ischaemia augments autophagy in association with BAG-1 protein , 2008, Journal of cellular and molecular medicine.

[125]  E. Cholongitas,et al.  Cirrhotics admitted to intensive care unit: the impact of acute renal failure on mortality , 2007, European journal of gastroenterology & hepatology.

[126]  L. Schaefer,et al.  Proteoglycans: from structural compounds to signaling molecules , 2009, Cell and Tissue Research.

[127]  P. Dagher,et al.  Pathways of renal injury in systemic gram‐negative sepsis , 2008, European journal of clinical investigation.

[128]  P. Beaune,et al.  Autophagy protects renal tubular cells against cyclosporine toxicity , 2008, Autophagy.

[129]  M. Omary,et al.  Autophagy activation by rapamycin eliminates mouse Mallory‐Denk bodies and blocks their proteasome inhibitor‐mediated formation , 2008, Hepatology.

[130]  M. Koike,et al.  Participation of autophagy in renal ischemia/reperfusion injury. , 2008, Biochemical and biophysical research communications.

[131]  M. Moore.  Autophagy as a second level protective process in conferring resistance to environmentally-induced oxidative stress , 2008, Autophagy.

[132]  N. Mizushima,et al.  Autophagy: process and function. , 2007, Genes & development.

[133]  A. Terzic,et al.  Deficiency of heme oxygenase-1 impairs renal hemodynamics and exaggerates systemic inflammatory responses to renal ischemia. , 2007, Kidney international.

[134]  V. Deretic,et al.  Unveiling the roles of autophagy in innate and adaptive immunity , 2007, Nature Reviews Immunology.

[135]  Zvulun Elazar,et al.  ROS, mitochondria and the regulation of autophagy. , 2007, Trends in cell biology.

[136]  D. Bolarin,et al.  Biochemical markers, extracellular components in liver fibrosis and cirrhosis. , 2007, Nigerian quarterly journal of hospital medicine.

[137]  T. Wynn,et al.  Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. , 2007, The Journal of clinical investigation.

[138]  K. Meldrum,et al.  TNF-α neutralization decreases nuclear factor-κB activation and apoptosis during renal obstruction , 2006 .

[139]  Marian F Young,et al.  The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. , 2005, The Journal of clinical investigation.

[140]  I. Vozár.  Serum laboratory markers for noninvasive diagnosis and monitoring of liver fibrogenesis in patients with chronic liver diseases. , 2005, Bratislavske lekarske listy.

[141]  D. Heinegård,et al.  Complexes of Matrilin-1 and Biglycan or Decorin Connect Collagen VI Microfibrils to Both Collagen II and Aggrecan* , 2003, Journal of Biological Chemistry.

[142]  C. Wanner,et al.  Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[143]  V. Arroyo,et al.  Hepatorenal syndrome. , 2003, Annals of hepatology.

[144]  D. Cha,et al.  Inflammatory Cytokines and Lipopolysaccharide Induce Fas-Mediated Apoptosis in Renal Tubular Cells , 2002, Nephron.

[145]  R. Timpl,et al.  Biglycan and Decorin Bind Close to the N-terminal Region of the Collagen VI Triple Helix* , 2001, The Journal of Biological Chemistry.

[146]  Kristi Kincaid,et al.  M-1/M-2 Macrophages and the Th1/Th2 Paradigm1 , 2000, The Journal of Immunology.

[147]  R. Rippe.  Role of transcriptional factors in stellate cell activation. , 1999, Alcoholism, clinical and experimental research.

[148]  B. Mayer,et al.  Nitric oxide synthases: catalytic function and progress towards selective inhibition , 1998, Naunyn-Schmiedeberg's Archives of Pharmacology.

[149]  F. Trevisani,et al.  Systemic and regional hemodynamics in pre-ascitic cirrhosis. , 1997, Journal of hepatology.

[150]  K. Schwarz,et al.  Expression of biglycan, decorin and proteoglycan-100/CSF-1 in normal and fibrotic human liver. , 1997, Pathology, research and practice.

[151]  A. Gressner,et al.  Regulation of proteoglycan expression in fibrotic liver and cultured fat-storing cells. , 1994, Pathology, research and practice.

[152]  A. Gressner,et al.  Biglycan and decorin gene expression in normal and fibrotic rat liver: Cellular localization and regulatory factors , 1992, Hepatology.